SNORA1: The Small Nucleolar RNA H/ACA Box 1 (G677792)

Target Name: SNORA1

NCBI ID: G677792

SNORA1

Other Name(s): Small nucleolar RNA, H/ACA box 1 | ACA1 | small nucleolar RNA, H/ACA box 1

SNORA1: The Small Nucleolar RNA H/ACA Box 1

Small nucleolar RNA (snRNA) is a class of non-coding RNA molecules that plays a critical role in the regulation of gene expression in eukaryotic cells. One of the most well-known snRNAs is H/ACA box 1 (SNORA1), which is a 24.1 kilobase (kb) RNA molecule that is expressed in a variety of tissues and cell types. The H/ACA box 1 gene is located on chromosome 16 and has been implicated in the regulation of gene expression, DNA replication, and other cellular processes.

The H/ACA box 1 gene is a member of the H/ACA box gene family, which is characterized by the presence of a specific motif known as the H/ACA box. This motif is composed of a highly conserved core sequence and a variable extension that is unique to each member of the family. The H/ACA box is a region of the snRNA molecule that is involved in the regulation of gene expression by binding to specific DNA sequences.

One of the unique features of SNORA1 is its expression pattern. SNORA1 is predominantly expressed in the cytoplasm of eukaryotic cells, where it is primarily localized to the nuclear envelope and the endoplasmic reticulum. It is also expressed in the nucleus, where it is involved in the regulation of gene expression. These observations suggest that SNORA1 may play a role in the regulation of cellular processes that are independent of the cytoplasm, such as DNA replication and other cell cycle-related processes.

The function of SNORA1 is not well understood, but it is known to be involved in the regulation of gene expression. Studies have shown that SNORA1 can interact with other snRNAs, including SnRNA2a, to regulate the translation of specific genes. This interaction between SNORA1 and SnRNA2a suggests that SNORA1 may be a negative regulator of gene expression, rather than a positive regulator.

Another potential function of SNORA1 is its role in DNA replication. Studies have shown that SNORA1 is involved in the regulation of DNA replication, specifically in the initiation of DNA replication. This suggests that SNORA1 may be a critical regulator of the DNA replication process, and that it may play a role in the development and progression of cancer.

In addition to its potential functions in gene expression and DNA replication, SNORA1 is also of interest as a drug target or biomarker. The H/ACA box is a well-conserved region of the snRNA molecule, which suggests that it may be a promising target for small molecule inhibitors. Several small molecules have been shown to interact with the H/ACA box, including inhibitors of the protein histamine receptor 5 (PAR-5) and the sphingomyelinase ASH2. These studies suggest that SNORA1 may be a potential drug target for small molecules, and that the H/ACA box may be an attractive target for drug development.

Conclusion

SNORA1 is a well-conserved small nucleolar RNA molecule that is expressed in a variety of tissues and cell types. Its expression pattern and interaction with other snRNAs suggest that it may play a role in the regulation of gene expression and DNA replication. As a potential drug target or biomarker, SNORA1 is of interest for the development of new therapeutic strategies for a variety of diseases. Further research is needed to fully understand the functions of SNORA1 and to determine its potential as a drug target or biomarker.

Protein Name: Small Nucleolar RNA, H/ACA Box 1

The "SNORA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets